199 followers
RT @dan_soffer: Mechanistic potential for PCSK9 mAb's in patients with high Lp(a) and nonHDLc/TGs https://t.co/xfOfT8xcIL
RT @dan_soffer: Mechanistic potential for PCSK9 mAb's in patients with high Lp(a) and nonHDLc/TGs https://t.co/xfOfT8xcIL
Mechanistic potential for PCSK9 mAb's in patients with high Lp(a) and nonHDLc/TGs https://t.co/xfOfT8xcIL
RT @XiangZhang18: Our latest @NgaleHealth #metabolomics study showed that the #PCSK9 inhibitor Evolocumab @Amgen markedly affected VLDL met…
RT @XiangZhang18: Our latest @NgaleHealth #metabolomics study showed that the #PCSK9 inhibitor Evolocumab @Amgen markedly affected VLDL met…